Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chen-Hua Li is active.

Publication


Featured researches published by Chen-Hua Li.


Experimental and Therapeutic Medicine | 2017

The efficacy of homemade tolcapone in the treatment of patients with Parkinson's disease

Pei-Lan Zhang; Yu-Xin Wang; Yan Chen; Chen-Hao Zhang; Chen-Hua Li

The aim of the study was to investigate the efficacy of homemade tolcapone in treatment of patients with Parkinsons disease (PD). Eighty patients with PD were subjected to randomized, double-blind, placebo-controlled and parallel-group study. PD patients were randomly divided into the tolcapone treatment group (41 cases) and placebo group (39 cases). Each patient received 1 pill of tolcapone or placebo, 3 times per day for 26 weeks. Efficacy was evaluated using the internationally used unified Parkinsons disease rating scale (UPDRS) scoring system for PD symptoms. After the treatment for 26 weeks, the cognitive function, tremor, muscle stiffness, voluntary movement and autonomic nerve symptoms were compared between the two groups using UPDRS scores. Compared with the placebo group, cognitive function, muscle stiffness and voluntary movement reduction were significantly improved in patients of the tolcapone group (P<0.05). However, no significant differences in UPDRS scores of autonomic nerve symptoms and tremor were found between two groups after treatment (P>0.05). Tolcapone, a catechol-O-methyl transferase (COMT) inhibitor, can improve the motor function of patients with PD, especially exercise and muscle stiffness. Tolcapone can also improve the cognitive function of patients.


Cell Biochemistry and Biophysics | 2015

Intravenous Thrombolytic Therapy for Acute Ischemic Stroke with Subclavian Arterial Steal Syndrome: A Case Report

Tong Xg; Yu-Xin Wang; Yan Chen; Chen-Hao Zhang; Chen-Hua Li; Zhong Dong; Xiaowei Zhang; Zhang Ff; Hang Yin; Jin-Huan Wang; Pei-Lan Zhang

This case study is of a patient who was a 71-year-old man, admitted to the emergency room due to ‘‘slurred speech and right limb weakness for 3.5 h’’. His symptoms started at 20:00 h, and the patient came to the hospital at 23:30 h on August 13, 2012. The patient had history of hypertension for 2 years, but no history of smoking/drinking or familial genetics. He experienced sudden slurred speech and right limb weakness at 20:00 h. The symptoms worsened quickly, and he was soon unable to express himself or understand words of others. Accompanying symptoms included poor mobility of the right limbs, and he was unable to lift or hold objects with the right upper limb, or could stand and walk with the right lower limb. There was no headache, dizziness, nausea, vomiting, unconsciousness, limb convulsion, or incontinence of urine and feces. As the patient’s symptoms persisted without relief, he visited the emergency room of our hospital immediately. Examination showed his blood pressure was 140/90 mmHg, heart rate 94 beats/min, irregular heart sound intensity with arrhythmia, and no pathological murmurs over all valve auscultation areas. The patient was alert with complete mixed aphasia. Both eye pupils were 3:3 mm, light reaction was positive, with eyes gazing to the left but no sign of nystagmus. Forehead wrinkles of the patient were symmetric. The patient could close the eyelids completely, but the right nasolabial fold was shallow. The tongue was in the midline, gag reflexes were positive, uvula centered in the midline, and the soft palate could lift naturally. The neck was soft, the myodynamia of left limb was achieved grade 5, and the myodynamia of right limb was achieved grade 1. The patient was uncooperative for other neurological examinations. National Institutes of Health Stroke Scale (NIHSS) of USA score was 15 points. Head CT scan suggested a widespread demyelination of bilateral cerebral hemispheres, as shown in Fig. 1. The relevant blood tests (including blood, coagulation, electrolytes, glucose, liver, and kidney function) did not show obvious abnormalities but ECG showed atrial fibrillation. Based on the guidelines of intravenous thrombolysis for acute ischemic cerebrovascular diseases, and the clinical and laboratory evaluations, the patient required intravenous rt-PA thrombolysis after admission. Therefore, rtPA thrombolytic therapy was administered 4 h after onset. The rt-PA dose was calculated at 0.9 mg/kg, 55 mg in total, which was first delivered with a 5.5 mg intravenous bolus for 1 min, and by intravenous infusion for the rest of 1 h. One hour after thrombolysis, the symptoms of speech disorders and the right limb weakness were slightly improved. Physical examinations showed that the patient was alert with complete motor aphasia and incomplete sensory aphasia. Pupils of both eyes were 3:3 mm, light reaction was positive; both eyes were gazing incompletely to the right, without nystagmus. Forehead wrinkles were symmetric. The patient could close the eyelids completely, but the right nasolabial fold was shallow. The tongue was in the midline, gag reflexes were positive, uvula centered in the midline, and the soft palate could lift naturally. The neck was soft, the myodynamia of left leg was achieved grade 5, the myodynamia of right upper limb was achieved grade 1, and the myodynamia of right lower limb was achieved grade 2. All limb muscle tensions were normal, tendon reflexes were positive, and right-side Babinski sign X.-G. Tong Y. Wang Y. Chen C. Zhang C.-H. Li Z. Dong X.-W. Zhang F.-F. Zhang H. Yin J.-H. Wang P.-L. Zhang (&) Department of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, No. 122, Qixiangtai Road, Tianjin 300060, China e-mail: [email protected]


European Review for Medical and Pharmacological Sciences | 2015

Study on the effect of urinary kallidinogenase after thrombolytic treatment for acute cerebral infarction.

Yu-Xin Wang; Yan Chen; Chen-Hao Zhang; Chen-Hua Li; Zhong Dong; Zhao Sn; Wang Z; Zhang Ff; Tong Xg; Jin-Huan Wang; Pei-Lan Zhang


European Review for Medical and Pharmacological Sciences | 2015

Safety and effectiveness of intravenous thrombolysis with recombinant tissue plasminogen activator in eighty years and older acute ischemic stroke patients.

Yan Chen; Chen-Hua Li; Yu-Xin Wang; Chen-Hao Zhang; Zhong Dong; Zhang Ff; Jin-Huan Wang; Pei-Lan Zhang


European Review for Medical and Pharmacological Sciences | 2015

Analysis on the correlation factors for hemorrhagic transformation after intravenous thrombolytic therapy.

Pei-Lan Zhang; Yu-Xin Wang; Yan Chen; Chen-Hao Zhang; Chen-Hua Li; Zhong Dong; Zhang Ss; Tong Yf; Li Yq; Tong Xg; Jin-Huan Wang


Minerva Medica | 2015

Optimal blood pressure levels in patients undergoing intravenous thrombolysis for AIS.

Chen-Hua Li; Yu-Xin Wang; Yan Chen; Chen-Hao Zhang; Zhong Dong; Zhang Ss; Tong Yf; Lv Z; Tong Xg; Jin-Huan Wang; Pei-Lan Zhang


Cell Biochemistry and Biophysics | 2015

Efficacy and Safety of Intravenous Thrombolysis for the Treatment of Acute Ischemic Stroke Patients with Saccular Intracranial Aneurysms of ≤3 mm.

Chen-Hao Zhang; Chen-Hua Li; Yu-Xin Wang; Yan Chen; Zhong Dong; Xiaowei Zhang; Zhang Ff; Hang Yin; Tong Xg; Jinhua Wang; Pei-Lan Zhang


Cell Biochemistry and Biophysics | 2015

Use of Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients: Evaluation of Clinical Outcomes.

Pei-Lan Zhang; Yu-Xin Wang; Yan Chen; Chen-Hao Zhang; Chen-Hua Li; Zhong Dong; Hang Yin; Zhang Ff; Jin-Huan Wang


Cell Biochemistry and Biophysics | 2015

Safety and Effectiveness of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in 80 Years and Older Acute Ischemic Stroke Patients

Yan Chen; Chen-Hua Li; Yu-Xin Wang; Chen-Hao Zhang; Zhong Dong; Zhang Ff; Jin-Huan Wang; Pei-Lan Zhang


Stroke | 2016

Abstract TP75: Safety and Outcome of Thrombolysis in Acute Stroke with Prolonged Onset-to-Treatment Times and Low National Institute of Health Stroke Scale Scores. Report on Experience in China, First 1000 Patients of 3300 Treated

Pei-Lan Zhang; Jin-Huan Wang; Yu-Xin Wang; Yan Chen; Chen-Hao Zhang; Chen-Hua Li; Zhong Dong; Jing Liang; Zuo Wang; Patrick Oliverio; Edward Greenberg; Nilesh Vyas; Lewis Eberly; John Cochran

Collaboration


Dive into the Chen-Hua Li's collaboration.

Top Co-Authors

Avatar

Zhang Ff

Tianjin University of Traditional Chinese Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nilesh Vyas

Inova Fairfax Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge